Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001095811-01-002046
Filing Date
2001-04-02
Accepted
2001-04-02 00:00:00
Documents
12
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K PERIOD END DECEMBER 31, 2000 a69091e10-k.txt 10-K 297771
2 EXHIBIT 10.8 a69091ex10-8.txt EX-10.8 30025
3 EXHIBIT 10.32 a69091ex10-32.txt EX-10.32 6125
4 EXHIBIT 10.33 a69091ex10-33.txt EX-10.33 24890
5 EXHIBIT 10.34 a69091ex10-34.txt EX-10.34 70122
6 EXHIBIT 10.35 a69091ex10-35.txt EX-10.35 1821
7 EXHIBIT 10.36 a69091ex10-36.txt EX-10.36 38998
8 EXHIBIT 10.37 a69091ex10-37.txt EX-10.37 39891
9 EXHIBIT 10.38 a69091ex10-38.txt EX-10.38 40300
10 EXHIBIT 10.39 a69091ex10-39.txt EX-10.39 17417
11 EXHIBIT 21 a69091ex21.txt EX-21 4039
12 EXHIBIT 23 a69091ex23.txt EX-23 844
  Complete submission text file 0001095811-01-002046.txt   575081
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
ICN PHARMACEUTICALS INC (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-11397 | Film No.: 1590968
SIC: 2834 Pharmaceutical Preparations